NEW YORK (GenomeWeb News) – Cyntellect said today that it will collaborate with the Boston University School of Medicine to research the role of mitochondrial oxidative damage in degenerative, aging, and metabolic diseases.

Under the agreement, BU scientists will use Cyntellect's LEAP cell-processing workstation to analyze, purify, and process cells within microplates.

Among the BU collaborators is Orian Shirihai, director of BU's Cell Imaging Core. Shirihai's research focuses on mitochondria and beta-cell function and dysfunction related to diabetes.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.

Mar
08
Sponsored by
Swift Biosciences

This webinar will discuss an optimized protocol for methyl-CpG binding domain sequencing (MBD-seq), which enables comprehensive, adequately powered, and cost-effective large-scale methylome-wide association studies (MWAS) of almost all 28 million CpG sites in the genome.